Angela Russell

Professor of Medicinal Chemistry

Angela Russell is a Professor of Medicinal Chemistry in the Department of Chemistry and Pharmacology at the University of Oxford. Her work lies at the interface of Chemistry, Biology and Medicine and aims to discover new small molecules and mechanisms to manipulate cell fate and translate them into therapeutic agents, particularly for degenerative diseases. Her work has led to two spin-out companies (MuOx in 2013, now part of Summit Therapeutics, and OxStem in 2016) and two clinical trials (in Duchenne muscular dystrophy and COVID-19).

In 2016, she was named as a ‘Rising Star’ in the ‘BioBeat 50 Movers and Shakers in BioBusiness 2016’ report. Released annually, the report celebrates 50 outstanding women entrepreneurs and business leaders who are recognised for their contributions to global health innovation. In 2020 she received a Harrington Rare Diseases scholarship award in recognition of her pioneering work to develop a therapy for Duchenne muscular dystrophy.